Inside these posts: AIDS

Visit our Filed page for categories. To browse by specific topic, see our Inside page. For a list of companies covered on this site, visit our Companies page.

 

Glaxo-Abbott case handed to the jury

A jury began deliberating Friday morning on whether Abbott Laboratories should pay GlaxoSmithKline hundreds of millions of dollars over allegations of unfair HIV drug pricing. Get the full story »

Glaxo: Abbott has illegal monopoly in AIDS drugs

From Bloomberg News | GlaxoSmithKline Plc lawyers, in a trial seeking at least $1.5 billion in damages, told jurors that Abbott Laboratories had an illegal monopoly over HIV drugs. Get the full story>>

India rejects Abbott patent of Kaletra AIDS drug

Abbott Laboratories was refused copyright protection on its AIDS drug Kaletra by India‚Äôs patent office, allowing Cipla Ltd. and other generic-drug companies to continue selling copies. Get the full story »

FDA approves Abbott HIV test

Abbott Labs said the FDA today approved its new diagnostic test that allows for earlier detection of HIV. Get the full story »